Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Post-ESWL urinary osteopontin level and ion-activity product of calcium oxalate are associated with stone recurrence after 5-year follow-up

Fig. 1

Changes in urinary expression of oxalate- and CaOx-related proteins. (a) NPC P62 (Nuclear pore complex oxalate binding protein p62, 62 kDa) in urine was significantly higher in pre-ESWL stone patients compared to the controls (b) Nucleolin (77 kDa) significantly increased at 2 weeks but notably decreased at 4 weeks. (c) SLC26A6 (90 kDa) significantly increased at 2 weeks but notably decreased at 4 weeks. (d) HA (Hyaluronic acid, 5.5 kDa) was significantly higher in pre-ESWL stone patients compared to the controls. HA significantly increased at 2 weeks but notably decreased at 4 weeks

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us